T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
E Naparstek(Hadassah Academic College), Shimon Slavin, C. Brautbar(Hadassah Medical Center), Zelig Tochner(Hadassah Medical Center), Reuven Or(Hebrew University of Jerusalem), Seth M. Steinberg(National Cancer Institute), Gabriel Cividalli(Hadassah Academic College), Arnon Nagler(Tel Aviv University), Noga Manny(Hadassah Medical Center), Lola Weiss(Hadassah Academic College), T. Sacks(Hadassah Medical Center), Herman Waldmann(University of Oxford), S Samuel(Hadassah Academic College), Dan Engelhard(Hadassah Academic College), G Hale(Union Bank of Switzerland), M Aker(Hadassah Medical Center), Z Gimon(Hadassah Medical Center)
Cited by 157
Related Papers
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
|The Journal of Experimental Medicine|2011|797